In this Editorial Article, Dr. Niklas Finnberg & Dr. Dorota Klaczkowska - Experts from Xbrane - discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerated timelines.
They also discuss the biosimilar development process, the integral role of bioassays in their work, and the potential of biosimilars to drive a future of more equitable healthcare systems.
